Abstract:Lyme disease, caused by Borrelia burgdorferi, is the most common tick-borne illness and an important emerging zoonosis in the United States and Europe. While most patients with Lyme disease can be cured with a 2-4 week antibiotic therapy with doxycycline, amoxicillin or cefuroxime, about 10%-20% patients continue to suffer persistent symptoms of fatigue, pain or joint and muscle aches, and neurocognitive manifestations that last 6 months or more despite the treatment, a condition called post-treatment Lyme disease syndrome (PTLDS). The cause for PTLDS is unclear but one possibility is persistent infection with B. burgdorferi. One intriguing feature of B. burgdorferi is its ability to develop variant forms such as round bodies and aggregated biofilm-like microcolonies as a log phase culture consisting primarily of spirochete forms grows older or under stress conditions. Here we isolated biofilm-like microcolony and planktopic form (spirochetal forms and ruond body) from stationary phase culture and compared the drug susceptibility of these different forms. We found that the stationary phase planktonic (SP) form and microcolony (MC) form of B. burgdorferi were much more tolerant to the current clinically used antibiotics, doxycycline, ceftriaxone and cefuroxime than log phase (LOG) spirochetal form. In addition, we also compared the ability of the variant forms to cause disease in a mouse arthritis model. Surprisingly, the SP form and particularly the MC form caused a more severe arthritis with an earlier onset of inflammation and joint swelling than the log phase spirochetal form. MC-infected mice showed significant joint swelling as early as 9 days post-infection, while the LOG form and SP form did not cause significant swelling. At 21 days, the joint swelling of the MC group dramatically increased and peaked; but the SP form showed significant swelling at this time but less severe than the MC infected group. The LOG infected mice were just beginning to develop joint swelling at Day 21 post-infection, with only slight swelling. At 30-day post infection, the SP group mice were also found to develop similar severity of joint swelling as the MC group, but the log phase group still did not show significant swelling. However, at 35-day post infection, all three infected groups showed similar degree of significant joint swelling. After 35-day infection, the joint swelling of the three infected groups relapsed during the 90-day observation. Thus, we developed a visual Lyme arthritis model using biofilm inocula that can be used for more efficient evaluation of treatment regimens for persistent B. burgdorferi infections. Our findings provide new insight about disease pathogenesis and may have implications for understanding PTLDS and recalcitrance of treatment with current Lyme antibiotics in PTLDS patients, due to possible biofilm inoculation during tick-bite.

Inflammation, biofilms and dietary measures in post treatment Lyme disease syndrome

What Makes It Tick: Exploring the Mechanisms of Post-treatment Lyme Disease Syndrome

Treatment of post‐treatment Lyme disease symptoms—a systematic review

Symptoms after Lyme disease: What's past is prologue

Stationary Phase Persister/biofilm Microcolony of Borrelia Burgdorferi Causes More Severe Disease in a Mouse Model of Lyme Arthritis: Implications for Understanding Persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and Treatment Failure.

Treatment trials for post-Lyme disease symptoms revisited

Persistent Borrelia Infection in Patients with Ongoing Symptoms of Lyme Disease

Biofilm Structures of Borrelia burgdorferi Not Only Display More Tolerance to Lyme Antibiotics But Also Cause More Severe Pathology In a Mouse Arthritis Model: Implications for Understanding Persistence, PTLDS and Treatment

Persistent Borrelia burgdorferi Sensu Lato Infection after Antibiotic Treatment: Systematic Overview and Appraisal of the Current Evidence from Experimental Animal Models

Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?

Early brain changes in Lyme disease are associated with clinical outcomes

Neuropsychiatric Lyme Disease and Vagus Nerve Stimulation

Lyme arthritis: linking infection, inflammation and autoimmunity

A Clinical Diagnostic System for Late-Stage Neuropsychiatric Lyme Borreliosis Based upon an Analysis of 100 Patients

Bridging the gap: Insights in the immunopathology of Lyme borreliosis

A Comprehensive Review of Herbal Supplements Used for Persistent Symptoms Attributed to Lyme Disease

A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease

Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis

Characterization of pathological IgE-mediated mast cell activation in Lyme disease

Memory and executive functions in adolescents with posttreatment Lyme disease

Clinical and laboratory characteristics during a 1‐year follow‐up in European Lyme neuroborreliosis: A prospective cohort study